This was the stock's fifth consecutive day of gains.

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 ...

In the latest trading session, Boston Scientific (BSX) closed at $106.53, marking a +1.86% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.52%. At ...

Shares of Boston Scientific Corp. BSX rose 1.72% to $104.12 Tuesday, on what proved to be an all-around favorable trading ...

Get the latest Boston Scientific Corporation (BSX) stock news and headlines to help you in your trading and investing decisions.

Boston Scientific agreed to pay Johnson & Johnson $600 million in connection with Johnson & Johnson’s botched acquisition of Guidant, a medical device company, in 2004.

Boston Scientific has put its 24-acre Minnetonka, Minnesota, campus up for sale as it continues to expand in nearby Maple Grove.

Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

Boston Scientific has become a big deal-maker under chief executive Mike Mahoney. – Topher Cox. For over a decade before the Guidant bidding war, Boston Scientific had been an aggressive deal-maker.

Learn about the executive team and board of directors at Boston Scientific Corp (BSX:XNYS) and review their bios and compensation over the latest fiscal years.

Boston Scientific raised its annual profit forecast and said strong demand for its medical devices would buffer a potential $200 million tariff-related hit, sending its shares up nearly 6% on ...